News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ADImmune Corporation Plans To Sell Its Flu Vaccine In China This Year



1/7/2014 11:29:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 7, 2013 -- Adimmune of Taiwan has completed a China Phase III trial of its trivalent flu vaccine in 1,200 people. It expects CFDA approval in mid-2014, which will allow the company to market the vaccine in mainland China in time for the 2014-2015 flu season, making it the first Taiwanese company to provide a vaccine to China. Adimmune is the only GMP-certified vaccine maker in Taiwan. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES